Trial
NCT02384746
Phase I Study of the Combination of MLN9708 and Fulvestrant
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
—
Condition
Breast Cancer
Intervention
Fulvestrant
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-29